Clinical trial
Effect of a Behavioral Intervention Delivered Via Telegram Messenger on Smoking Cessation in Patients After Myocardial Infarction: The TELEGRAM-MI Randomized Controlled Trial
NCT07230249 is registered in ClinicalTrials.gov with ITMO University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of a Behavioral Intervention Delivered Via Telegram Messenger on Smoking Cessation in Patients After Myocardial Infarction: The TELEGRAM-MI Randomized Controlled Trial
- Lead sponsor
- ITMO University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 27, 2026
- Completion date
- August 1, 2027
- Enrollment
- 142 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myocardial infarction (mi), smoking cessation, tobacco use